Medifast, Inc.
MED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $193 | $732 | $1,291 | $2,451 |
| - Cash | $91 | $94 | $88 | $104 |
| + Debt | $16 | $22 | $26 | $33 |
| Enterprise Value | $118 | $659 | $1,230 | $2,380 |
| Revenue | $602 | $1,072 | $1,599 | $1,526 |
| % Growth | -43.8% | -32.9% | 4.8% | – |
| Gross Profit | $445 | $776 | $1,140 | $1,128 |
| % Margin | 73.8% | 72.4% | 71.3% | 73.9% |
| EBITDA | $16 | $140 | $196 | $223 |
| % Margin | 2.6% | 13% | 12.2% | 14.6% |
| Net Income | $2 | $99 | $144 | $164 |
| % Margin | 0.3% | 9.3% | 9% | 10.7% |
| EPS Diluted | 0.19 | 9.1 | 12.73 | 13.89 |
| % Growth | -97.9% | -28.5% | -8.4% | – |
| Operating Cash Flow | $24 | $148 | $195 | $95 |
| Capital Expenditures | -$7 | -$6 | -$17 | -$34 |
| Free Cash Flow | $17 | $141 | $178 | $60 |